Adient plc (ADNT) CEO granted 14,866 RSUs, now holds 636,182 shares

Rhea-AI Filing Summary

Adient plc reported an insider equity transaction for its President and CEO, who also serves as a Director. On 01/01/2026, the executive received a grant of 14,866 restricted stock units at a price of $0. These units are scheduled to vest on the one-year anniversary of the grant date, with continued or accelerated vesting in certain termination, death, or disability situations.

On the same date, 5,234 ordinary shares were withheld at a price of $19.17 to cover taxes related to the vesting of restricted stock units or performance share units. After these transactions, the executive beneficially owned 636,182 ordinary shares, held directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dorlack Jerome J.

(Last) (First) (Middle)

49200 HALYARD DRIVE

(Street)

PLYMOUTH MI 48170

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Adient plc [ ADNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
01/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	01/01/2026		A		14,866(1)	A	$0	641,416	D
Ordinary Shares	01/01/2026		F		5,234(2)	D	$19.17	636,182	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects a grant of restricted stock units that will vest upon the one year anniversary of the grant date (subject to continued vesting upon involuntary termination without cause, or accelerated vesting upon death or disability).

2. Withholding of shares to cover taxes due in connection with the vesting of restricted stock units or performance share units, as applicable.

Remarks:

	/s/ Brett L. Eilander, Attorney-in-fact for Jerome J. Dorlack	01/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Adient plc (ADNT) report for 01/01/2026?

Adient plc reported that its President and CEO, who is also a Director, received a grant of 14,866 restricted stock units on 01/01/2026 and had 5,234 ordinary shares withheld to cover taxes related to equity vesting.

How many Adient plc (ADNT) shares does the reporting executive own after the transaction?

Following the reported transactions, the executive beneficially owned 636,182 ordinary shares of Adient plc, held in direct ownership.

What are the vesting terms of the 14,866 restricted stock units at Adient plc (ADNT)?

The 14,866 restricted stock units will vest on the one-year anniversary of the grant date, with continued vesting upon certain involuntary terminations without cause and accelerated vesting upon death or disability.

Why were 5,234 Adient plc (ADNT) shares withheld in this insider filing?

The 5,234 ordinary shares were withheld to cover taxes due in connection with the vesting of restricted stock units or performance share units.

What roles does the reporting person hold at Adient plc (ADNT)?

The reporting person is identified as both a Director and an Officer, serving as President and CEO of Adient plc.

Were the Adient plc (ADNT) restricted stock units granted for cash consideration?

No cash consideration was paid for the grant; the 14,866 restricted stock units were reported with a price of $0.